![Rod’s Keynote speech: Perils Facing the Hemp and Cannabinoid Industry [Video]](https://cannabislaw.report/wp-content/uploads/2022/06/cropped-favicon-32x32-1.png)
Rod’s Keynote speech: Perils Facing the Hemp and Cannabinoid Industry [Video]
In this keynote speech Rod addresses perils facing the hemp industry, including the threat posed by Big Marijuana, cannabis associations that purport to advocate for hemp while promoting corporate marijuana interests, and the current crisis for hemp in NC. Rod also discusses important federal law issues and practical recommendations for the hemp industry.
The Source Rule is Alive and Well
The Source Rule, which says that the source of a cannabinoid determines its legal status, is embedded into the legal fabric of the cannabis industry. In this article I respond to arguments claiming that the Source Rule is dead and show that, far from dead, it is now more relevant than ever.
Continue reading “The Source Rule is Alive and Well”…
The post The Source Rule is Alive and Well first appeared on Kight on Cannabis.
Virginia Stomps Its Local Hemp Industry With New Law
Virginia’s attempt to provide further clarity regarding hemp extract and hemp-derived products has instead resulted in additional and onerous regulations that challenge the vitality of an industry it once strongly supported.
Continue reading “Virginia Stomps Its Local Hemp Industry With New Law”…
The post Virginia Stomps Its Local Hemp Industry With New Law first appeared on Kight on Cannabis.
DEA Seed Letter – Triumph or Trap?
Since the DEA’s Seed Letter became public I have fielded a number of calls from clients about selling cannabis seeds. Everyone wants to know if it is possible to sell cannabis seeds and other low-THC cannabis materials, such as cannabis clones, and stay out of legal trouble. The answer is, “It depends”.
Continue reading “DEA Seed Letter – Triumph or Trap?”…
The post DEA Seed Letter – Triumph or Trap? first appeared on Kight on Cannabis.
US Customs At DFW Is Arresting People & Seizing Their Hemp Products
Rod Kight writes, ““One single, small amount of CBD oil that you thought was cool to take on a trip with you, could result in life-changing effects,” says Dallas Fort Worth International Airport (DFW) US Customs (CBP) Port Director Cleatus Hunt Jr.”
Buckle Up- What If The 2018 Farm Bill Is Not Enacted In September?
The Agricultural Act of 2014, also knowns as the 2014 Farm Act (Act), will expire on September 30, 2018.
California Goes Off the Rails About CBD
The California Department of Public Health (CDPH), Food and Drug Branch (FDB), released a new FAQ, “Industrial Hemp and Cannabidiol (CBD) in Food Products” on July 6, 2018 (FAQ). The FAQ specifically states that CBD may not be introduced into food products:
WHO Issues Glowing Report of CBD But Gets the Law Wrong- A Legal Analysis
The World Health Organization (WHO) issued a Critical Review Report (Report) on cannabidiol (CBD) on June 7, 2018. The Report is an update and extension of the Pre-Review Report on CBD that was prepared by Professor Jason White of Australia and released in November 2017 (Pre-Report) to the Expert Committee on Drug Dependence (ECDD). The Report was one of several issued about cannabis during a meeting in Geneva, Switzerland by a group of international cannabis experts. It was prepared by Dr Sharon Walsh and Dr Susanna Babalonis of Kentucky and J. Rehm of Canada and presented to the ECDD. It is the first of many steps by the WHO to deliver a recommendation to the UN secretary-general on the “need for and level of international control” of cannabis, which could have a major impact on marijuana legislation internationally.
Did the Federal Right to Try Act Just Legalize Medical Marijuana?
I’ve heard and read a lot this week about how the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 (Right to Try Act), signed into law by President Trump on May 30, 2018, functions to legalize medical marijuana. It does no such thing. What it appears to do is allow terminally ill patients to try investigational new drugs that have not yet been approved by the FDA.
A Legal Analysis of the DEA Directive Regarding Cannabinoids
To say that the DEA is is slow in responding to matters regarding cannabis (other than raids and arrests) is like saying that Rip Van Winkle took a long nap. It’s a complete understatement. As reported by Lisa Rough in Leafly, “the first petition to reschedule cannabis from Schedule I to Schedule II was filed in 1972 by the National Organization for the Reform of Marijuana Laws (NORML), but the petition was not given a hearing for fourteen years.” In the article, Rough goes on to discuss another petition filed by Americans for Safe Access and the Coalition for Rescheduling Cannabis in 2002, which was ultimately denied in 2011, nine years later.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.